EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer

Autor:	Belli, Stefania, Esposito, Daniela, Ascione, Claudia M., Messina, Francesca, Napolitano, Fabiana, Servetto, Alberto, De Angelis, Carmine, Bianco, Roberto, Formisano, Luigi
Zdroj:	In Cancer Letters 1 July 2024 593
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect